SEC Form 4 · accession 0001415889-17-000346
Medovex Corp. · MDVX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jarrett S Gorlin
Officer — CHIEF EXECUTIVE OFFICER · Director
Period of report
Feb 3, 2017
Accepted (ET)
Feb 27, 2017 · 8:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001591165
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to Purchase Common StockF1 | $1.13 | Feb 3, 2017 | A | 48,142 | A | Feb 3, 2017 | Feb 3, 2027 | Common Stock | 48,142 | 48,142 | D |
Explanation of responses
- F1The options shall vest and become exercisable in four (4) installments as follows: the first installment to purchase 25% of the common stock underlying the options vested on February 3, 2017. The balance of the options, or 75%, shall vest in three equal installments at a rate of 25% on February 3, 2018, February 3, 2019 and February 3, 2020.